Our Team

Our founder-led, interdisciplinary team has been involved in the approval of 25 drugs and the investigation of more than 100.

Leadership

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Strategy Officer

Adam Savitz, MD, PhD

Chief Medical Officer

Wei Wu, PhD

Co-Founder and Chief Data Science Officer

Nick Smith

Chief Financial Officer

Mikael Eliasson, MD, PhD

Chief Operating Officer

Fadi Abdel, PhD

Vice President, Clinical Innovation

Bruce Morimoto, PhD

Vice President, Drug Development

Jessica Powell

Vice President, Clinical Operations

Scientific Advisors

Tom Insel, MD

Former Director, NIMH

Madhukar Trivedi, MD

Professor, UTSW

Alan Schatzberg, MD

Professor, Stanford

Fei-Fei Li, PhD

Professor, Stanford

Quentin Huys, PhD

Associate Professor, University College London

Board of Directors

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Strategy Officer

Gwill York, MBA

Founding Managing Director, Lighthouse Capital Partners

Aaron Weaver

Principal, Apeiron Investment Group

Jeff Chen, PhD

Managing Director, Alkeon Capital Management

Christopher Nixon Cox, JD

CEO, Lightswitch Capital

Receive updates from Alto
Thanks for signing up!
Oops! Something went wrong while submitting the form.